Delivery Order SPE2DB22D1002-SPE2DB25FLHV3
- Not listed
- The Defense Logistics Agency (DLA) awarded a $3,793.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents. The contract, issued on July 14, 2025, is scheduled for ultimate completion by August 4, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order was competitively awarded without any set-aside designation, demonstrating the contractor's capability to compete in open federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,053.01 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of September 11, 2025. This competitive award, issued on August 20, 2025, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,158.88 on August 14, 2025, for Varivax vaccine with diluents to be delivered to Conshohocken, Pennsylvania, with a completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,211.84 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on September 9, 2025, with an ultimate completion date of September 30, 2025. This competitively awarded, firm fixed-price contract requires no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a $3,096.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract reflects AmerisourceBergen's critical role as a pharmaceutical distributor supporting federal medical procurement needs. The delivery order is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,106.02 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on August 11, 2025, with an ultimate completion date of September 2, 2025, utilizes firm fixed pricing under a non-set-aside competitive procurement. Performance of this delivery order will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $10,321.10 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on August 12, 2025, carries a firm fixed price structure with an ultimate completion date of September 3, 2025. This is a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $157,951.50 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, executed on August 27, 2025, is a firm fixed-price delivery order with an ultimate completion date of September 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and...
- The Defense Logistics Agency awarded a delivery order valued at $10,530.10 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on August 26, 2025, utilizes firm fixed pricing and carries an ultimate completion date of September 17, 2025. This non-competitive delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the vendor's critical role in the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents valued at $10,529.60 under a firm fixed price contract. This competitively awarded delivery order, with an ultimate completion date of September 30, 2025, represents a continuation of the vendor's ongoing pharmaceutical supply relationship with DLA. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLHV3Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,096.33 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on September 18, 2025, with an ultimate completion date of October 9, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction under DLA's pharmaceutical procurement framework. The vaccine will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting federal medical supply requirements for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As one of the federal government's primary pharmaceutical distributors, AmerisourceBergen leverages this comprehensive IDC vehicle to supply a broad range of pharmaceutical products and medical supplies, including vaccines, specialty medications, and related medical commodities to support military healthcare programs globally. The company's demonstrated capability to fulfill federal medical procurement requirements through open competition positions it as a critical vendor within DLA's pharmaceutical supply chain and broader healthcare support operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 9/18/25 |